Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market to witness a CAGR Growth of 8.80% | Market is Projected to Worth of $8,860.22 Million by 2028 | Key Players Change the View of the Global Face of Industry


WASHINGTON, March 31, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research published a report, titled, "Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size, Share & Trends Analysis Report by Product & Service (qPCR Products & Services, dPCR Products & Services), by Application (qPCR Applications, dPCR Applications), by End User (qPCR End User, dPCR End User), by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)". According to the report, the global Digital PCR (dPCR) and Real-time PCR (qPCR) industry generated $ 5,341.60Million in 2021, and is anticipated to generate $ 8,860.22 Million by 2028, witnessing a CAGR of 8.80% from 2022 to 2028.

Synopsis:

The rising incidents of genetic disorders, target infectious disease, and increasing use of biomarker profiling for the disease diagnostics, and the successful completion of the Human Genome Project are the major factors driving the growth of Digital PCR (dPCR) and Real-time PCR (qPCR) Market during the forecast period. The rising technological advancements in PCR technologies, growing investments, funds, and grants are expected to increase the demand for Digital PCR (dPCR) in the upcoming years. Growth in the occurrence of target diseases globally attached with the verified efficiency of Digital PCR (dPCR) and Real-time PCR (qPCR) Market analysis in the diagnosis and the valuation of disease-causing microbes, which will drive the utilization of clinical diagnostic tests including Digital PCR (dPCR) and Real-time PCR (qPCR) Market analysis which is expected to contribute to the growth of the market during the forecast period. The growing market penetration in the emerging countries and shifting of consumers' opinions from plant-delivered drugs to the genome-based drugs is projected to boost the market growth during the forecast period. Moreover, the transition of the plant to genome-based drug discovery is expected to offer the opportunity for the growth of digital PCR (dPCR) and Real-time PCR (qPCR) Market in the upcoming years. Besides, the technical limitations related to PCR and the increased cost of PCR devices are projected to hinder the growth of the Digital PCR (dPCR) and Real-time PCR (qPCR) Market during the forecast period.

Please Check Out Our Free Sample Reports and Make a More Informed Decision:

Get Access to a Free Copy of Our Latest Sample Report @ https://www.vantagemarketresearch.com/digital-pcr-dpcr-and-realtime-pcr-qpcr-market-1370/request-sample

(Sample reports are a great way to test our in-depth reports or study before you make a purchase)

  • The newly updated, 135+ page reports provide an in-depth analysis of the COVID-19 virus and pandemic.
  • Using industry data and interview with experts, you can learn about topics such as regional impact analysis, global forecast, competitive landscape analysis, size & share of regional markets.
  • We offer these reports in PDF format so you can read them on your computer and print them out.
  • Free sample includes, Industry Operating Conditions, Industry Market Size, Profitability Analysis, SWOT Analysis, Industry Major Players, Historical and Forecast, Growth Porter's 5 Forces Analysis, Revenue Forecasts, Industry Trends, Industry Financial Ratios.
  • The report also presents the country-wise and region-wise analysis of the Vantage Market Research and includes a detailed analysis of the key factors affecting the growth of the market.
  • Sample Report further sheds light on the Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis, to offer the readers an advantage over others.

Key Insights & Findings from the Report:

  • According to our primary respondents’ research, the Digital PCR (dPCR) and Real-time PCR (qPCR) market is predicted to grow at a CAGR of roughly 8.80% during the forecast period.
  • The Digital PCR (dPCR) and Real-time PCR (qPCR) market was estimated to be worth roughly USD 5,341.60 Million in 2021 and is expected to reach USD 8,860.22 Million by 2028; based on primary research.
  • On the basis of region, North America is projected to dominate the worldwide Digital PCR (dPCR) and Real-time PCR (qPCR) market.

List of Prominent Players in the Digital PCR (dPCR) and Real-time PCR (qPCR) Market:

  • Thermo Fisher Scientific (US)
  • Bio-Rad Laboratories Inc. (US)
  • and F. Hoffmann-La Roche Ltd. (Switzerland)
  • Abbott Laboratories (US)
  • Agilent Technologies (US)
  • Analytik Jena AG (Switzerland)
  • Becton Dikinson and Company (US)
  • bioMérieux SA (France)
  • Danaher Corporation (US)
  • Eppendorf (Germany)
  • Fluidigm Corporation (US)
  • Merck KGaA  (Germany)
  • QIAGEN N.V.  (Netherlands)
  • Takara Bio (Japan)
  • Meridian Bioscience (US)
  • Promega Corporation (US)
  • Enzo Life Sciences, Inc. (US)
  • Bioneer (South Korea)
  • ELITech Group (France)
  • Quidel Corporation (US)

Purchase This Premium Report Now @ https://www.vantagemarketresearch.com/buy-now/digital-pcr-dpcr-and-realtime-pcr-qpcr-market-1370/0

Benefits of Purchasing Digital PCR (dPCR) and Real-time PCR (qPCR) Market Reports:

  • Customer Satisfaction: Our team of experts assists you with all your research needs and optimizes your reports.
  • Analyst Support: Before or after purchasing the report, ask a professional analyst to address your questions.
  • Assured Quality: Focuses on accuracy and quality of reports.
  • Incomparable Skills: Analysts provide in-depth insights into reports.

Market Dynamics:

Drivers:

The development of portable, compact, and lab-on-chip PCR devices and the current technological integration with the PCR processes are the major factors driving the growth of the Digital PCR (dPCR) and Real-time PCR (qPCR) Market during the forecast period. The growing investments and availability of funds for PCR-based research and the rising incidents of target infectious diseases are driving the growth of the global Digital PCR (dPCR) and Real-time PCR (qPCR) Market.

Challenges:

The high equipment costs, especially that of dPCR, and the occurrence of technical limitations of PCR are the major factors hindering the growth of the global Digital PCR (dPCR) and Real-time PCR (qPCR) Market during the forecast period.

Regional Trends:

North America is projected to acquire the largest market share during the forecast period. The growth in the North American Digital PCR (dPCR) and Real-time PCR (qPCR) Market is mainly attributed to the increasing adoption of advanced and original genomic analysis products including innovative Digital PCR (dPCR) and Real-time PCR (qPCR) Market products. The growth in the availability of Research and Development fundings for genomic research connected with the robust research infrastructure available in the region is increasing the growth of the Digital PCR (dPCR) and Real-time PCR (qPCR) Market in North America. North America is growing due to the early commercialization of Digital PCR (dPCR) and Real-time PCR (qPCR) Market products as compared with the other regions. The North American region including Canada and United Kingdom is projected to be the largest market owing to the increased funding for Digital PCR (dPCR) and Real-time PCR (qPCR) Market technologies.

Asia Pacific region is projected to grow at the highest CAGR owing to rapidly developing economies, rise in the government support for life science research, growth in the aging population connected with the growth in the incidence of genetic diseases, growing research, and the clinical trial out-sourcing from the region which is expected to increase the demand of Digital PCR (dPCR) and Real-time PCR (qPCR) Market in the Asia Pacific region.

Read Full Research Report @ https://www.vantagemarketresearch.com/industry-report/digital-pcr-dpcr-and-realtime-pcr-qpcr-market-1370

Recent Developments:

  • In 2020, Thermo Fisher Scientific, Inc received US FDA emergency use authorization (EUA) for SARS-CoV-2 multiplex real-time PCR test.
  • In 2020, Roche Diagnostics acquired FDA 510k clearance for the Cobas BKV test.

The report on the Digital PCR (dPCR) and Real-time PCR (qPCR) Market highlights:

  • Assessment of the market
  • Premium Insights
  • Competitive Landscape
  • COVID Impact Analysis
  • Historic Data, Estimates, and Forecast
  • Company Profiles
  • Global and Regional Dynamics

Browse market data Tables and Figures spread through Pages and in-depth TOC on "Digital Pcr (Dpcr) And Qpcr Market by Product (instruments, consumables, services) by Application (clinical diagnostic, research, forensic) by end-user (clinical laboratories, pharmaceutical companies, clinical research organization, academic research institutes) , by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa): Global Market Assessment, 2021 – 2028" View detailed Research Report here – https://www.vantagemarketresearch.com/press-release/digital-pcr-dpcr-and-qpcr-market-326160

Key questions answered in the report:

  • Which regional market will show the highest and rapid growth?
  • Which are the top five players of the Digital Pcr (Dpcr) And Qpcr Market?
  • How will the Digital Pcr (Dpcr) And Qpcr Market change in the upcoming six years?
  • Which application and product will take a lion’s share of the Digital Pcr (Dpcr) And Qpcr Market?
  • What is the Digital Pcr (Dpcr) And Qpcr market drivers and restrictions?
  • What will be the CAGR and size of the Digital Pcr (Dpcr) And Qpcr Market throughout the forecast period?        

This market titled “Digital PCR (dPCR) and Real-time PCR (qPCR) Market” will cover exclusive information in terms of Geographic Segmentation, Forecast, Regional Analysis, Key Market Trends, and various others as mentioned below:

ParameterDetails
Market Size in 2021USD 5,341.60 Million
Projected Market Size in 2028USD 8,860.22 Million
CAGR Growth RateCAGR of 8.80% From 2022 – 2028
Market Size Provided for Years2016-2028
Base Year2021
Historic Years2016-2020
Forecast Years2022-2028
Segments Covered
  • Product & Service
    • qPCR Products & Services
    • dPCR Products & Services
  • Application
    • qPCR Applications
    • dPCR Applications
  • End User
    • qPCR End User
    • dPCR End User
Region & Counties Covered
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • U.K
    • France
    • Germany
    • Italy
    • Spain
    • Rest Of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South East Asia
    • Rest Of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest Of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest Of Middle East & Africa
Companies Covered
  • Thermo Fisher Scientific (US)
  • Bio-Rad Laboratories Inc. (US)
  • and F. Hoffmann-La Roche
  • Ltd. (Switzerland)
  • Abbott Laboratories (US)
  • Agilent Technologies (US)
  • Analytik Jena AG (Switzerland)
  • Becton Dikinson and Company (US)
  • bioMérieux SA (France)
  • Danaher Corporation (US)
  • Eppendorf (Germany)
  • Fluidigm Corporation (US)
  • Merck KGaA  (Germany)
  • QIAGEN N.V.  (Netherlands)
  • Takara Bio (Japan)
  • Meridian Bioscience (US)
  • Promega Corporation (US)
  • Enzo Life Sciences, Inc. (US)
  • Bioneer (South Korea)
  • ELITech Group (France)
  • Quidel Corporation (US)
Report CoverageMarket growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

Customization of the Report:

The report can be customized as per client needs or requirements. For any queries, you can contact us on sales@vantagemarketresearch.com or +1 (202) 380-9727. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.

Download Free Sample Report Now @ https://www.vantagemarketresearch.com/digital-pcr-dpcr-and-realtime-pcr-qpcr-market-1370/request-sample

Browse More Related Report:

About Vantage Market Research:

We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.

Follow Us on LinkedIn: https://www.linkedin.com/company/vantage-market-research/

Follow Us on Twitter: https://twitter.com/vantagemarketr

Contact us

Eric Kunz

6218 Georgia Avenue NW Ste 1 - 564

Washington DC 20011-5125

United States Tel: +1 202 380 9727

Email: sales@vantagemarketresearch.com

Website: https://www.vantagemarketresearch.com/

Latest Vantage Market Research Press Releases @ https://www.vantagemarketresearch.com/insight/press-releases

Latest Vantage Market Research Blog @ https://www.vantagemarketresearch.com/insight/blogs

Blog: